LONGEVA.
··

Bacteriostatic Water reference

> Updated:

Human schedule

This is a diluent, not an active substance with a human dose.

This is a concise reference to regimens described for adults; it is not an individual prescription.

Bacteriostatic water for injection has no dose of its own: the volume added to a peptide vial only sets the final concentration, not the activity or effect of the dissolved substance.

Period / conditionDoseEscalation
DiluentNo dose of its own; volume is determined by the concentration in the specific laboratory protocolNot applicable
Practical dosing and effect details

Bacteriostatic Water for Injection, USP has no active ingredient or dose of its own: here, "dose" means the volume of diluent added to a given amount of lyophilized peptide, not a fixed number. For example, 2 mL of diluent into a vial with 5 mg of peptide gives a concentration of 2.5 mg/mL; the same vial reconstituted with 1 mL gives 5 mg/mL instead, twice the concentration for the same amount of substance. An error in this calculation shifts not the diluent's properties but the dose of the active substance itself: a larger volume lowers the concentration and requires drawing a larger volume for the same peptide dose, while a smaller volume raises the risk of measurement error when drawing small amounts with a microsyringe. The preservative in the formulation, benzyl alcohol (0.9-1.1%), suppresses bacterial growth across repeated punctures of the stopper: under the USP <797> standard and manufacturer labeling (Pfizer, Hospira), an opened vial is used for no more than 28 days. This is reference information about reconstitution for research protocols, not a medical recommendation and not instructions for self-administration.

This reference is research-use material. The information is not medical advice and is not intended for diagnosis, treatment or prevention of disease.